Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Navarrete

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
BMC Medical Research Methodology|July 27, 2021
A multiyear systematic survey of the quality of reporting for randomised trials in dentistry, neurology and geriatrics published in journals of Spain and Latin AmericaVivienne C Bachelet, María S Navarrete, Constanza Barrera-Riquelme, et al.
Biorxiv : the Preprint Server for Biology|December 4, 2023
An arginine-rich nuclear localization signal (ArgiNLS) strategy for streamlined image segmentation of single-cellsEric R Szelenyi, Jovana S Navarrete, Alexandria D Murry, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 29, 2024
An arginine-rich nuclear localization signal (ArgiNLS) strategy for streamlined image segmentation of single cellsEric R Szelenyi, Jovana S Navarrete, Alexandria D Murry, et al.
Molecular Microbiology|May 5, 2012
The conserved polarity factor podJ1 impacts multiple cell envelope-associated functions in Sinorhizobium melilotiAlexander T Fields, Charlene S Navarrete, Alaa Ziad Zare, et al.
The Journal of Nutrition, Health & Aging|November 14, 2023
Resistance Exercise Program in Cognitively Normal Older Adults: CERT-Based Exercise Protocol of the AGUEDA Randomized Controlled TrialB Fernandez-Gamez, P Solis-Urra, M Olvera-Rojas, et al.
ACS Pharmacology & Translational Science|March 15, 2019
DREADD Agonist 21 Is an Effective Agonist for Muscarinic-Based DREADDs <i>in Vitro</i> and <i>in Vivo</i>Karen J Thompson, Elham Khajehali, Sophie J Bradley, et al.
Frontiers in Immunology|October 18, 2021
Immune Profile and Clinical Outcome of Breakthrough Cases After Vaccination With an Inactivated SARS-CoV-2 VaccineLuisa F Duarte, Nicolás M S Gálvez, Carolina Iturriaga, et al.
Medrxiv : the Preprint Server for Health Sciences|April 20, 2022
A booster dose of an inactivated SARS-CoV-2 vaccine increases neutralizing antibodies and T cells that recognize Delta and Omicron variants of concernBárbara M Schultz, Felipe Melo-González, Luisa F Duarte, et al.
Iscience|August 18, 2025
Age and primary vaccination schedule impact humoral and cellular immunity with an inactivated SARS-CoV-2 vaccineYohana Martínez-Balboa, Linmar Rodríguez-Guilarte, Constanza Méndez, et al.
Elife|October 13, 2022
Differences in the immune response elicited by two immunization schedules with an inactivated SARS-CoV-2 vaccine in a randomized phase 3 clinical trialNicolás M S Gálvez, Gaspar A Pacheco, Bárbara M Schultz, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
BMC Medical Research Methodology|July 27, 2021
A multiyear systematic survey of the quality of reporting for randomised trials in dentistry, neurology and geriatrics published in journals of Spain and Latin AmericaVivienne C Bachelet, María S Navarrete, Constanza Barrera-Riquelme, et al.
Biorxiv : the Preprint Server for Biology|December 4, 2023
An arginine-rich nuclear localization signal (ArgiNLS) strategy for streamlined image segmentation of single-cellsEric R Szelenyi, Jovana S Navarrete, Alexandria D Murry, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 29, 2024
An arginine-rich nuclear localization signal (ArgiNLS) strategy for streamlined image segmentation of single cellsEric R Szelenyi, Jovana S Navarrete, Alexandria D Murry, et al.
Molecular Microbiology|May 5, 2012
The conserved polarity factor podJ1 impacts multiple cell envelope-associated functions in Sinorhizobium melilotiAlexander T Fields, Charlene S Navarrete, Alaa Ziad Zare, et al.
The Journal of Nutrition, Health & Aging|November 14, 2023
Resistance Exercise Program in Cognitively Normal Older Adults: CERT-Based Exercise Protocol of the AGUEDA Randomized Controlled TrialB Fernandez-Gamez, P Solis-Urra, M Olvera-Rojas, et al.
ACS Pharmacology & Translational Science|March 15, 2019
DREADD Agonist 21 Is an Effective Agonist for Muscarinic-Based DREADDs <i>in Vitro</i> and <i>in Vivo</i>Karen J Thompson, Elham Khajehali, Sophie J Bradley, et al.
Frontiers in Immunology|October 18, 2021
Immune Profile and Clinical Outcome of Breakthrough Cases After Vaccination With an Inactivated SARS-CoV-2 VaccineLuisa F Duarte, Nicolás M S Gálvez, Carolina Iturriaga, et al.
Medrxiv : the Preprint Server for Health Sciences|April 20, 2022
A booster dose of an inactivated SARS-CoV-2 vaccine increases neutralizing antibodies and T cells that recognize Delta and Omicron variants of concernBárbara M Schultz, Felipe Melo-González, Luisa F Duarte, et al.
Iscience|August 18, 2025
Age and primary vaccination schedule impact humoral and cellular immunity with an inactivated SARS-CoV-2 vaccineYohana Martínez-Balboa, Linmar Rodríguez-Guilarte, Constanza Méndez, et al.
Elife|October 13, 2022
Differences in the immune response elicited by two immunization schedules with an inactivated SARS-CoV-2 vaccine in a randomized phase 3 clinical trialNicolás M S Gálvez, Gaspar A Pacheco, Bárbara M Schultz, et al.
Pageof 8